bluebird bio Inc
(NAS:BLUE)
$
0.405
0.0272 (7.2%)
Market Cap: 78.75 Mil
Enterprise Value: 376.50 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 31/100 bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019 / 10:00PM GMT
Release Date Price:
$82.01
(+1.77%)
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research
Let's get started with the next session. So my name is Ying Huang. I'm the senior biotech analyst covering large-cap biotech here at BofA Merrill Lynch. And we're very pleased to have our next presenting company bluebird bio. We have CEO -- well, actually, I should say Chief bluebird, Nick Leschly, from bluebird. And I think...
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
I'm proud of you right now, and that's good.
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research
Thank you. Appreciate it. So, Nick will probably have a few slides and some prepared remarks and then we'll go into Q&A after that. With that, let me welcome Nick to Vegas, I remember last year we had some accident the with the air traffic situation. So I'm glad you are here in (inaudible).
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
(inaudible)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot